UK Biobank has been featured in three prominent publications recently, with scientists acknowledging its critical place in future health research.
In the American Journal of Epidemiology, Dr Teri Manolio, at the National Human Genome Research Institute, USA, discusses how the UK Biobank concept might be possible in the US, though in all likelihood, at much greater cost. She says: “Large, prospective studies are indispensable for the identification of causes of disease…” She says there are useful lessons to learn from the UK Biobank experience. “A key lesson from UK Biobank and similar studies is that large studies are not simply small studies made large but, rather, require fundamentally different approaches in which “process” expertise is as important as scientific rigor.”
The Public Health Journal says that biobanks are becoming a key resource and ‘goldmines’ for research. “With an emphasis on efficient, high quality procedures, tested in a number of pilot studies, the UK Biobank has set the standard for modern population-based biobanking,” it says.
The UK’s prestigious health journal The Lancet carried a Commentary on UK Biobank which it hopes will encourage scientists to use the resource.
You can read more about these studies on the UK Biobank Resources page of this website.